Demography, disease, and presentation characteristics
| Valaciclovir treatment | |||
|---|---|---|---|
| 3 days (n=259) | 5 days (n=272) | Total (n=531) | |
| Male/female (%) | 44/56 | 48/52 | 46/54 |
| Median age (years, range) | 34 (18–76) | 36 (16–81) | 35 (16–81) |
| Pain severity at treatment initiation (%) | |||
| None/mild | 52 | 58 | 55 |
| Moderate/severe | 48 | 42 | 45 |
| HSV isolated pretreatment (day 0) (%) | 35 | 36 | 35 |
| Time from first signs/symptoms to start of treatment: | |||
| ≤6 hours (%) | 50 | 46 | 48 |
| Median (hours, range) | 6.1 (0–291) | 8.0 (0–187) | 7.3 (0–291) |